PDIA3 and liver cancer: The research by Takata et al. and Liu et al. [21, 22] suggested that the high expression of PDIA3 presaged a poor prognosis for patients with liver cancer, and PDIA3 might be a key molecule in the developing new targeted therapies for liver cancer.